annual current liabilities:
$27.41M+$8.28M(+43.26%)Summary
- As of today (May 29, 2025), VKTX annual total current liabilities is $27.41 million, with the most recent change of +$8.28 million (+43.26%) on December 31, 2024.
- During the last 3 years, VKTX annual current liabilities has risen by +$18.64 million (+212.29%).
- VKTX annual current liabilities is now at all-time high.
Performance
VKTX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$19.57M-$7.84M(-28.60%)Summary
- As of today (May 29, 2025), VKTX quarterly total current liabilities is $19.57 million, with the most recent change of -$7.84 million (-28.60%) on March 31, 2025.
- Over the past year, VKTX quarterly current liabilities has dropped by -$13.20 million (-40.28%).
- VKTX quarterly current liabilities is now -40.28% below its all-time high of $32.77 million, reached on March 31, 2024.
Performance
VKTX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
VKTX Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.3% | -40.3% |
| 3 y3 years | +212.3% | +73.7% |
| 5 y5 years | +304.5% | +129.1% |
VKTX Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +212.3% | -40.3% | +73.7% |
| 5 y | 5-year | at high | +304.5% | -40.3% | +129.1% |
| alltime | all time | at high | >+9999.0% | -40.3% | +4386.1% |
VKTX Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $19.57M(-28.6%) |
| Dec 2024 | $27.41M(+43.3%) | $27.41M(+6.7%) |
| Sep 2024 | - | $25.68M(+2.4%) |
| Jun 2024 | - | $25.09M(-23.4%) |
| Mar 2024 | - | $32.77M(+71.3%) |
| Dec 2023 | $19.14M(-12.8%) | $19.14M(+42.7%) |
| Sep 2023 | - | $13.40M(-0.5%) |
| Jun 2023 | - | $13.48M(-13.9%) |
| Mar 2023 | - | $15.65M(-28.7%) |
| Dec 2022 | $21.95M(+150.0%) | $21.95M(+56.1%) |
| Sep 2022 | - | $14.06M(-5.4%) |
| Jun 2022 | - | $14.86M(+31.9%) |
| Mar 2022 | - | $11.27M(+28.4%) |
| Dec 2021 | $8.78M(-27.6%) | $8.78M(-22.7%) |
| Sep 2021 | - | $11.35M(-11.8%) |
| Jun 2021 | - | $12.87M(-0.3%) |
| Mar 2021 | - | $12.92M(+6.5%) |
| Dec 2020 | $12.13M(+79.0%) | $12.13M(+24.8%) |
| Sep 2020 | - | $9.71M(+7.3%) |
| Jun 2020 | - | $9.05M(+6.0%) |
| Mar 2020 | - | $8.54M(+26.0%) |
| Dec 2019 | $6.78M | $6.78M(+9.4%) |
| Sep 2019 | - | $6.19M(+10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $5.63M(+14.4%) |
| Mar 2019 | - | $4.92M(+8.1%) |
| Dec 2018 | $4.55M(-47.4%) | $4.55M(-4.1%) |
| Sep 2018 | - | $4.74M(+15.5%) |
| Jun 2018 | - | $4.11M(-35.2%) |
| Mar 2018 | - | $6.34M(-26.8%) |
| Dec 2017 | $8.66M(+33.7%) | $8.66M(-9.9%) |
| Sep 2017 | - | $9.61M(+24.4%) |
| Jun 2017 | - | $7.73M(+128.5%) |
| Mar 2017 | - | $3.38M(-47.8%) |
| Dec 2016 | $6.48M(+227.6%) | $6.48M(+6.6%) |
| Sep 2016 | - | $6.08M(+5.9%) |
| Jun 2016 | - | $5.74M(+199.2%) |
| Mar 2016 | - | $1.92M(-3.0%) |
| Dec 2015 | $1.98M(-91.2%) | $1.98M(-65.5%) |
| Sep 2015 | - | $5.72M(+17.4%) |
| Jun 2015 | - | $4.88M(-82.4%) |
| Mar 2015 | - | $27.71M(+23.1%) |
| Dec 2014 | $22.52M(>+9900.0%) | $22.52M(-6.1%) |
| Jun 2014 | - | $23.97M(+5393.5%) |
| Mar 2014 | - | $436.30K |
| Dec 2013 | $127.50K(+134.4%) | - |
| Dec 2012 | $54.40K | - |
FAQ
- What is Viking Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Viking Therapeutics?
- What is Viking Therapeutics annual current liabilities year-on-year change?
- What is Viking Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Viking Therapeutics?
- What is Viking Therapeutics quarterly current liabilities year-on-year change?
What is Viking Therapeutics annual total current liabilities?
The current annual current liabilities of VKTX is $27.41M
What is the all time high annual current liabilities for Viking Therapeutics?
Viking Therapeutics all-time high annual total current liabilities is $27.41M
What is Viking Therapeutics annual current liabilities year-on-year change?
Over the past year, VKTX annual total current liabilities has changed by +$8.28M (+43.26%)
What is Viking Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of VKTX is $19.57M
What is the all time high quarterly current liabilities for Viking Therapeutics?
Viking Therapeutics all-time high quarterly total current liabilities is $32.77M
What is Viking Therapeutics quarterly current liabilities year-on-year change?
Over the past year, VKTX quarterly total current liabilities has changed by -$13.20M (-40.28%)